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Abstract 
Immobilized Artificial Membrane (IAM) chromatography constitutes a valuable tool for medicinal chemists 
to prioritize drug candidates in early drug development. The retention on IAM stationary phases encodes 
lipophilicity, electrostatic and other secondary interactions contrary to traditional octanol-water 
partitioning. An increasing number of publications in recent years have suggested that IAM indices, 
including isocratic log k(IAM) or extrapolated log kw(IAM) retention factors, chromatographic hydrophobicity 
index CHI(IAM) or the polarity parameter Δlog kw(IAM) can successfully model the passage of xeniobiotics 
through biological membranes and barriers and predict pharmacokinetic properties, often in combination 
with additional descriptors. Examples referring to the modeling of human oral absorption, blood-brain 
penetration and skin partition are described. More recently, IAM chromatography has been applied to 
estimate toxicological endpoints in regard to drug safety, such as phospholipidosis potential, or in regard to 
chemical risk hazards including the bioconcentration factor and aquatic organisms’ toxicity. The promising 
results in both medicinal chemistry and in environmental science in combination with the speed, 
reproducibility and low analyte consumption suggest that a broader application of IAM chromatography in 
the early drug discovery process and in ecotoxicity may save time and money in initial drug candidate 
selection and will contribute to a reduced risk hazard of chemicals.  
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Introduction to IAM Chromatography 
High-performance liquid chromatography (HPLC) is a powerful analytical technique based on the 
differentiation in the elution of different compounds in a given sample when passed through a 
chromatographic column (stationary phase) by the flow of a mobile phase. Thus, dissolved in the mobile 
phase chemicals participate in a dynamic equilibrium between the mobile and stationary phase and their 
elution expresses their distribution coefficients between the two phases, depending on various primary 
and secondary interactions. As several pharmacokinetic and ecotoxicological properties involve a dynamic 
distribution of xenobiotics between general circulation and tissues, or aqueous environment and tissues of 
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aquatic organisms, HPLC can be used in order to predict pharmacokinetic properties and environmental 
risk indices. The strategy and the key advantages of using HPLC as a tool to achieve biomimetic conditions 
have been addressed by Valko [1,2]. 
The use of a chromatographic index (e.g. retention factor) as a measure of a biological endpoint (e.g. 
pharmacokinetic properties, toxicity and ecotoxicological profile) has generated quantitative retention- 
activity relationships (QRAR) [3]. The main advantage of QRAR is that it is not necessary to know the values 
of the molecular descriptors of the compound under investigation in order to estimate its pharmacokinetic 
or ecotoxicological profile as in classic quantitative structure-activity relationship (QSAR) studies. This is 
important in the case of new compounds. 
The first attempt of introducing HPLC to the modelling of biological processes with the employment of 
reversed-phase liquid chromatography as an alternative for lipophilicity assessment was made in order to 
overcome certain disadvantages of direct partitioning experiments [4]. Lipophilicity was known as a 
predominant determinant in drug transport across membranes as proved by the traditional Hansch 
analysis [5]. The development of biomimetic chromatographic columns provided a substantial advance for 
the experimental evaluation of ADMET properties in the early stages of drug/chemical development, 
combining the simulation of biological processes with rapid measurements [6-8]. In pharmaceutical and 
environmental sciences three types of biomimetic chromatography are used; immobilized artificial 
membrane (IAM), immobilized plasma protein chromatography as well as biopartitioning micellar 
chromatography (BMC). The first two types are based on biomimetic stationary phases, IAM and 
immobilized plasma protein (i.e. human serum albumin and Alpha-1 acid glycoprotein), respectively. The 
third uses reversed phase columns and the biological environment is mimicked by micellar mobile phases 
obtained upon addition of a surfactant above its critical micellar concentration [9,10]. The retention under 
biomimetic conditions is referred to as biomimetic properties which may play an essential role in the drug 
design process of selecting the appropriate compound with the right pharmacokinetic/ toxicological profile 
to become an effective drug [11]. Biomimetic chromatography has the advantage of combining simulation 
of the biological environment with high speed, is economic and user friendly and requires only a small 
amount of the analyte without the necessity to be pure [12,13]. 
Of particular importance is the modelling of biological membranes which constitute barriers, which 
bioactive compounds have to cross in order to reach their molecular target and exert their 
pharmacological actions or their potential adverse effects. Membrane permeability can be modeled by a 
range of approaches, starting with the traditional octanol-water partitioning, or liposomes partitioning and 
proceeding to the development of different cell cultures or artificial membrane assays, IAM 
chromatography however, constitutes a powerful alternative due to its superior performance in terms of 
the simplicity of the experiments, high throughput, reproducibility and the possibility of automation. In this 
present review, the latest advances in IAM chromatography in both the pharmaceutical and the 
environmental sciences are presented and discussed. 
Types of IAM stationary phases and their interrelation 
IAM stationary phases are prepared by immobilization of phospholipids (e.g. phosphatidylcholine) on 
propylamino-silica skeleton. At present, three types of IAM columns are commercially available; the single 
chain IAM.PC (PC stands for “phosphatidylcholine”); the double-chain IAM.PC.MG (MG stands for 
“methylglycolate”) and the IAM.PC.DD2 (DD stands for “drug discovery”). According to its producer IAM.PC 
and IAM.PC.MG are suggested for “membrane protein purification”, while IAM.PC.DD2 is recommended 
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for drug discovery purposes. IAM.PC.DD2 is available in 3, 10 and 15 cm long columns, IAM.PC in 15 and 30 
cm columns, while IAM.PC.MG is produced in 3 and 15 cm length columns. All types of the columns have 
an i.d. of 4.6 mm and a stationary phase of 10 μm particle size. An IAM fast- screen mini column (1 cm x 
3mm) is also available for rapid estimations of drug permeability in high- throughput screening programs 
for the characterization of large libraries of compounds [14]. 
According to the literature, not only the IAM.PC.DD2 column but also the IAM.PC.MG column are widely 
employed in pharmaceutical [15-20] and environmental research [21]. The difference between the two 
columns is in the end-capping of the free (unreacted) propylamino residues, performed either by 
methylglycolate or decyl/propyl anhydride as described in detail in the literature [6,7,22-24]. Previous 
comparative investigations on the two IAM stationary phases using a structurally diverse set of compounds 
[16,18,25-27] showed a similar underlying elution mechanism with an almost 1:1 correlation between the 
retention factors measured in a pure aqueous phase, log kw(IAM). A representative interrelationship based 
on 161 structurally diverse compounds is expressed by Eq.(1) [27]: 
Log kw(IAM.DD2) = 0.1437 + 1.0757 · log kw(IAM.PC.MG)    (1) 
(N=161, R2=0.93, s=0.314) 
Where N is the number of compounds, R
2
 is the correlation coefficient and s is the standard deviation. 
The similarity between the two columns permits the combination of retention factors measured on 
both IAM stationary phases in order to model biological processes. 
IAM indices and conditions used 
The most common approach for the employment of IAM chromatography is the simple determination 
of the retention factor of the solute, according to Eq. (2): 
0
0




   
(2) 
where tr is the retention of the test compound and t0 is the elution time of an unretained compound, such 
as sodium citrate, L- cysteine or ammonium oxalate [28]. The IAM retention factor, k(IAM), is proportional to 
the partition coefficient, K(IAM), between the IAM stationary phase and the mobile phase according to 
equation (3): 







where Vs and Vm are the volumes of stationary and mobile phase, respectively, whose ratio for a given 
column is constant. For IAM.PC.DD2, Vs/Vm is equal to 0.053 [29] and, therefore, the k(IAM)/K(IAM) relation is 
given according to Eq. (4): 




   
(4) 
In modelling biological processes or ecotoxicity, retention factors are usually used in their logarithmic 
form in order to achieve linear relationships with free energy. IAM measurements are performed at 
ambient temperature [17,20,26,30-34] contrary to biopartitioning micellar chromatography which is 
usually employed at 36.5-37.0 °C [9, 10]. Mobile phases consist of a buffer, typically phosphate-buffered 
saline (PBS) in order to mimic physiological conditions. A limitation in the preparation of mobile phases is 
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their pH value, which should be adjusted to between 2.5 and 7.4. Although it is common to add an organic 
modifier to the mobile phases, IAM stationary phases can also be used with a pure aqueous phase 
[26,28,31,34,35]. In such cases, the measured log k(IAM) values correspond to the actual log kw(IAM) values, 
where the symbol “w” denotes the pure aqueous phase. In the case of compounds exhibiting strong 
affinity with the IAM stationary phase, acetonitrile can be added up to concentrations of 30 % and 
log kw(IAM) values can be obtained by linear extrapolation of isocratic log k(IAM) values, measured in the 
presence of at least four different acetonitrile fractions (φ) in the mobile phase, according to Eq.(5): 
log  = log  -  × (IAM) w(IAM)k k S φ   (5) 
where S is the slope of the log k vs φ relationship, calculated by linear regression. Comparative studies 
between actual and extrapolated log kw(IAM) values showed only small differences [17,26]. Such findings 
permit the combined use of actual log kw(IAM) values with extrapolated values in the case of lipophilic 
compounds. However, the use of mobile phases with high concentration of acetonitrile should be avoided 
as the structure of water layer on the stationary phase surface can be disrupted [36]. The use of methanol 
as an organic modifier should also be avoided as it can cause instability of the stationary phase due to 
methanolysis of the phospholipids [37,38]. To this point, the high inter- and intra-laboratory reproducibility 
of actual or extrapolated log kw(IAM) values under standard conditions (buffer PBS and acetonitrile as organic 
modifier) should be highlighted [7]. 
As an alternative to using IAM retention factors, Valko has proposed the chromatographic 
hydrophobicity index for IAM chromatography, CHI(IAM) [1,39,40], which, in recent literature, has been also 
termed as “membrane binding index” (IAM MB) [41]. CHI(IAM) corresponds to the percentage of acetonitrile 
required for the equal partitioning of the solute between the mobile and the stationary phase (e.i. log k=0), 
which according to Eq.(5) is equal to φ0 = log kw(IAM)/ S. The rapid determination of CHI(IAM) [1,39] can be 
easily performed by the measurement of the gradient elution times (tg) measured under the appropriate 
gradient conditions. The obtained tg for each analyte is converted to its CHI(IAM) value by using a linear 
calibration equation regression line CHI(IAM)= f(tg) obtained by using 9 standard compounds, namely 
octanophenone, heptanophenone, hexanophenone, valerophenone, butyrophenone, propiophenone, 
acetophenone, acetanilide and paracetamol [39]. In such experiments usually, ammonium acetate is the 
buffer, which is compatible with mass spectrometry, while acetonitrile is the organic modifier [39].  
CHI(IAM) can be further converted to log kw(IAM) for the neutral form of the molecule by means of Eq.(6) 
which was established from 86 diverse drug molecules [11].  
log kw(IAM)=0.046 CHI(IAM) +0.42   (6) 
(n=86, R2=0.94, s=0.29)    
Relationship of IAM retention with lipophilicity and other molecular factors 
In order to unravel the potential applications of IAM chromatography in pharmaceutical and 
environmental sciences, it is crucial to investigate the elution mechanism, governing the IAM retention 
mechanism. There is general agreement that IAM retention is governed by lipophilicity, involving 
hydrophobicity, polarity and the additional factors, of electrostatic interactions in the case of ionizable 
compounds (e.g. deprotonated acids, protonated bases and zwitterions) with the charged centres of the 
phospholipids and the consequent formation of ionic bonds [17,21,26,31,34,38]. In such cases, IAM 
retention may be considered as a border case between passive diffusion and binding as was highlighted by 
Van Balen et al. [42]. The specific contribution of each parameter to the so-called “phospholipophilicity” 
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can be expressed by Eq. (7) and has been discussed in a previous review [7,8]: 
Phospholipophilicity =  Hydrophobicity ± Polarity + Electrostatic interactions  (7) 
The sign of polarity in Eq. (7) can be negative reducing phospholipophilicity in an analogous manner to 
its effect on lipophilicity, or positive as a result of hydrogen bonding to the glycerol ester group of the 
phospholipids. Electrostatic interactions lead overall to enhanced retention, although repulsive forces 
between solute anions and IAM phosphate groups may also occur. 
The crucial role of hydrophobicity to IAM retention can be highlighted by considering log kw(IAM)/ log P 
relationships, which are generally characterized by good statistics. In the case of ionizable compounds 
log kw(IAM) may still correlate better with log P than log D as a result of the partial compensation of 
ionization via electrostatic interactions [26]. However, the relationship of log kw(IAM) with log D can be 
considerably improved by introducing the positively (F+) or negatively charged (F-) molecular fraction of the 
analytes [17,21,26,31,34] as additional parameters. Positive signs (higher for F
+
 than for F
-
) are generated, 
as shown in Eq. (8) at pH=7.4, supporting the overall positive contribution of electrostatic interactions. 
+ -log  =  0.62 × log  + 1.14 × F  + 0.48 × F + 0.327.4w(IAM)k D       
  (8) 
(n= 56, R2= 0.938, s= 0.413) 
The roustness of Equation (8) has been sucessfully validated by other sets of structurally diverse drugs 
[17,26]. 
Other authors have confirmed the electrostatic interactions in IAM retention using linear free energy 




 for ionic 
species) as additional parameters [43,44]. A representative equation obtained at pH=7.0 is shown in Eq. (9) 
[44]:  
log kw(IAM)= -0.607 + 0.881 · E – 0.562 · S – 0.348 · A- 1.794 · B + 2.250 · V -0.245 · J
+ + 2.010 · J-   (9) 
(n=68, R2= 0.896, s=0.431) 
In Eq. (9), the solute descriptors are as follows: V is the McGowan’s characteristic volume, E is the 
excess molar refraction, S is the dipolarity/polarizability, and A and B are the hydrogen-bond acidity and 
basicity, respectively.  
The additional terms, δ-correction or J+ and J- have positive signs (higher for cations than for anions).  A 
possible explanation for the stronger electrostatic interactions of cations is the location of the IAM 
phosphate groups close to the hydrophobic part of phospholipids, in contrast to the choline nitrogen which 
is more exposed to the solvent effect at the outer terminal of the IAM surface [21,26]. Thus, phosphate 
anions enhance the partitioning of cations into the IAM stationary phase by attraction forces, while as 
already commented, repulsive forces may occur with anions [21,26]. However, in the case of very 
hydrophilic anions, partitioning into the hydrophobic core may not be the determinant factor and 
attraction by the positively charged choline nitrogen becomes similarly important. In such cases, retention 
is mainly governed by electrostatic interactions [17]. 
Comparative block relevance analysis of PLS models based on Volsurf descriptors further supports the 
similar information content of log kw(IAM) and log P for neutral compounds. As for bases and acids the 
analysis of log kw(IAM) (and also of log P) generates a positive sign for the block of H-bond donor (HBD) 
properties in accordance with the enhanced affinity to the IAM stationary phase , favoured for cations over 
anions , while the opposite sign (negative) is observed   in the log D  model [45]. 
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The contribution of hydrogen bonding has also been reported [7,25,31,34] and Barbato [46] has 
discussed the role of glycerol as a hydrogen acceptor in solute retention. This may be the reason for only 
the moderate interrelation between log kw(IAM) on the two columns, IAM.PC.DD2 and IAM.PC.MG obtained 
for a set of 41 flavonoids, mainly as a result of their different content in alcoholic hydroxyl groups [20].  
The polar/electrostatic interactions can be expressed as (Δlog kw(IAM)), which is the difference between 
the experimental log kw(IAM) value and the log kw(IAM) estimated by a calibration equation of log kw(IAM) versus 
log P, which is obtained for neutral compounds, interacting with the IAM stationary phase by a purely 
hydrophobic mechanism. Δlog kw(IAM) is higher for poorly lipophilic compounds, while high lipophilicity 
produces negative values [16,18,19,25].  
As confirmed also by block relevance analysis at least for neutral compounds, Δlog kw(IAM) is considered 
as a polarity index, which can be used in QSPR studies replacing other polarity parameters such as polar 
surface area (PSA) or Δlog Poct-alk [45].  
Recently, the contribution of secondary interactions due to residual silanol and propylamine groups to 
the elution mechanism on IAM stationary phases has been investigated. Such secondary interactions are 
attributed to the change of the net charge of the IAM surface as a function of pH. At pH > 5 there is an 
overall negative charge on the IAM surface due to the predominance of ionized silanol groups, while at 
lower pH protonated propylamine groups prevail resulting in a positive charge. Hence, at physiological 
conditions, an increased retention capacity of protonated bases can be anticipated and therefore, an 
overestimation of the affinity of such compounds to phospholipids. The resulting electrostatic effect is 
more pronounced in low salinities of eluents [47]. The role of silanophilic interactions in IAM retention has 
also been reported by other authors [30,34,38]. 
The identification of the molecular factors expressed in IAM retention has provided tools for in silico 
prediction of phospholipophilicity. Ledbetter et al. [48] developed an algorithm for the prediction of 
log kw(IAM) values of compounds based on fragments and correction factors using a data set which consisted 
of 22 aliphatic and 42 aromatic compounds. Recently, Russo et al. [27] proposed a model for prediction of 
log kw(IAM) values, involving four in silico calculated parameters; lipophilicity, hydrophilic/ lipophilic balance, 
molecular size and molecular flexibility. The work was based on their measurements on 205 experimental 
values made by them on IAM.PC.DD2 and IAM.PC.MG column types, to minimize inter-laboratory 
variability, leading to a good degree of accuracy (R2= 0.85).  
The applications of IAM chromatography to predict ADMET properties in pharmaceutical sciences 
Interactions between drugs and immobilized phospholipids, expressed in IAM retention, can serve as 
important indices for various processes, such as drug permeability and absorption (considering passive 
diffusion as the main process), tissue and subcellular distribution as well as toxicity due to functional and 
morphological changes in cells as for instance phospholipidosis. Comparative studies have shown that IAM 
retention factors correlate with Caco-2 permeability [49-51] or with permeability through MDCK cell lines, 
two standard protocols which used to measure permeability in vitro [17].  
Of significant importance are the applications of IAM chromatography to model gastrointestinal 
absorption/ bioavailability. It is known that passive permeation routes for drugs involve diffusion through 
the aqueous pores at the tight junctions, the so-called paracellular absorption and transcellular absorption 
through the enterocyte itself [52]. Published investigations have reported mainly the establishment of non- 
linear models for transcellular based human oral absorption (HOA) combining IAM retention with other 
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physicochemical properties, such as molecular weight (MW) or polarity terms. Yoon et al. reported a 
sigmoidal model for a data set of 40 structurally diverse drugs [53] using isocratic retention factors 
corrected with MW to the nth power. The best fit was obtained for k(IAM) with n=2.5. The same group 
continued their study combining IAM retention with hepatic metabolic clearance to model the oral 
absorption potential for a limited set of 15 drugs [54]. Yen et al. reported a reciprocal correlation between 
the negative value of the IAM retention factor (-1/k(IAM)) and human intestinal absorption for 52 drugs 
(R=0.64). This correlation was further improved upon the inclusion of molecular descriptors expressing 
molecular size and shape, solubility and polarity (R=0.83) [55]. Kotecha et al. suggested that as intestinal 
absorption occurs along the gastrointestinal tract and mainly in the small intestine with a pH gradient, the 
maximum log kw(IAM), measured in a certain pH range (e.g. 4.5-7.4) and defined as 
best
w(IAM)log k  should be 
considered [32,33]. The general model proposed by Kotecha et al. is a sigmoidal function of %HOA, which 
can be improved by additional physicochemical parameters, leading to the general Eq. (10): 
 - α + α  × X + α  × X  + …+ α Xn n1 10 2 2
100
% HOA = 
1 + 10 
  (10) 
where X1 stands for 
best
w(IAM)log k , X2, X3, ..Xn are additional physicochemical properties and α0, α1, α2, .., αn 
are regression coefficients obtained by non-linear fitting. The best model for 27 structurally diverse drugs 
was obtained using bestw(IAM)log k  in combination with the polar surface area [33]. Tsopelas et al. used an 
extended data set of 85 drugs to fit bestw(IAM)log k in Eq. (10). They obtained successfully validated models by 
including MW, the Abraham’s hydrogen-bond acidity parameter (A), both with a negative sign, and the 
negatively charged molecular fraction with a positive sign. If zwitterions were excluded from the data set 
the model will include MW and positively charged molecular fraction (F+), both with a negative sign. The 
negative sign of F
+
 indicates that electrostatic interactions with the phosphate anions on the IAM surface 
are over expressed and may be associated with the binding component, reflecting drug-membrane 
interactions besides membrane permeability. Analogous models in terms of statistics and predictive 
performance were obtained by replacing the IAM retention factors with octanol-water distribution 
coefficients. The main difference between the two models relies on the opposite sign of the F+ parameter 
(positive in the log Dbest model, negative in the IAM model) attraction forces to the negatively charged 
inner membrane, which do play a role in absorption but are not expressed in the octanol-water system. In 
addition, the hydrogen bond acidity A is statistically non-significant in the log Dbest model [17].  
IAM retention factors have also served to model blood-brain barrier (BBB) penetration in combination 
with other physicochemical parameters such as molecular volume and structural indices. In an early study, 
the performance of IAM to model BBB penetration (log BB) was compared with octanol-water partitioning. 
The log BB/ log kw correlations were slightly inferior in terms of statistics when compared to the 
corresponding log BB/ log P data. Molecular volume was statistically significant with a negative 
contribution in both models [56]. Reichel and Begley found a significant correlation between the logarithm 
of brain uptake indices divided by the square root of the molecular weight (log BUI) of six biogenic amines 
with IAM retention (R2=0,747), although the same indices for six steroids correlated better with 
computational clogP than with log kw(IAM)  (R
2= 0.809 and R2= 0.729, respectively) [57]. Pehourcq et al. 
reported a parabolic relationship for the diffusion of cerebrospinal fluid (CSF) for a set of eight amyl 
propionate non-steroidal anti-inflammatory drugs. The inclusion of molecular weight led to an improved 
model [58]. Grumetto et al. established also parabolic relationships for the BBB passage for a set of 14 
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basic drugs with retention on either IAM.PC.MG or IAM.PC.DD2 stationary phases. However, the better 
model obtained with log P directed the authors to use the Δlog kw(IAM) parameter, assuming that the 
electrostatic interactions were encoded in the IAM retention as a factor that hinders drugs from 
transmembrane penetration [59]. They established significant linear negative log BB/ Δlog kw(IAM), which 
were confirmed for an enlarged set of 40 structurally diverse drugs [25]. More recently, they have 
proposed a partial least square (PLS) model based on isocratic IAM retention factors in the presence of 
30 % MeOH and in silico calculated physicochemical and topological indices. The PLS model constructed for 
79 structurally unrelated analytes had however slightly inferior statistics to that obtained with retention 
factors on biopartitioning micellar chromatography in the presence of sodium dodecyl sulfate (SDS) [10]. 
Grumetto et al. [19] have found a parabolic relationship between log BB and log kw(IAM) or Δlog kw(IAM)
,
 
measured on an IAMDD2 column, with an opposite sign for the linear term (R2= 0.825 and R2= 0.826 
respectively).  Results were inferior when an IAM.MG column was used. Better parabolic relationships, 
however, were obtained with log P of the neutral form (R
2
=0.880) [59]. The same research group 
performed a comparative study between IAM retention indices (log kw(IAM) and Δlog kw(IAM)) and PAMPA 
using a porcine brain lipid extract for the prediction of in situ BBB permeability where they found the 
Δlog kw(IAM) parameter to be more efficient than PAMPA [19]. 





).  The best model was obtained using kw(IAM)/MW
4
 measured at pH values of 5.5 and 
7.0, with cut- off values equal to 1.01 and 0.85, respectively. 
Efforts have also been made for the employment of IAM chromatography as a tool to model the 
transdermal transport of drugs. In a comparative investigation, Lazaro et al. explored the potential of IAM 
and C18 stationary phases. They suggested that IAM can mimic skin partition but that skin permeation is 
closer to elution on reversed-phase columns [30]. Barbato et al. investigated a limited set of 12 drugs and 
used both the log kw(IAM) and the Δlog kw(IAM) parameters with no correlation of skin permeability have been 
observed with log kw(IAM), but a negative correlation with Δlog kw(IAM) was evident, indicating that polar and 
electrostatic interactions hinder molecules from crossing the skin layer, possibly due to repulsive forces 
[61]. 
A point of major importance lies in early drug safety assessment. Considering the binding component of 
the IAM retention mechanism, a high affinity to IAM stationary phases in the case of basic amphiphilic 
drugs may be considered as an indication of drug-induced phospholipidosis, a situation associated with 
excessive accumulation of phospholipids within lysosomes [62,63]. Investigations have shown good 
correlation between IAM-CHI indexes and phospholipidosis risk [64] or phospholipidogenic potential [65]. 
In terms of CHI(IAM) a value > 50 may be related to phospholipidosis [41]. In a comparative study of 36 
drugs, Jiang and Reilly developed a simple and rapid physicochemical screening approach based on 
chromatographic methods for predicting the potential of compounds to induce phospholipidosis [66]. They 
found an equally satisfactory correlation with the retention on electrokinetic chromatography based on 
docusate sodium salt (R2=0.87 and R2=0.86 respectively) or with the logarithm of the volume of distribution 
log Vd calculated from IAM chromatography (CHI-IAM) and human serum albumin chromatography, 
according to Εq. (11) as suggested by Hollosy et al [40]. 
log Vd = 0.44 · log K(IAM) – 0.22 log K(HSA) -0.66   (11) 
(n= 179, R2= 0.76, s= 0.33) 
An analogous relationship, resulting from a combination of retention on both IAM and HSA stationary 
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phases was reported by Valko et al. [67] to predict the unbound volume of distribution (Vdu), defined as the 
volume of distribution divided by the unbound fraction (fu) of the drug in plasma:  Vdu=Vd/fu.  
log Vdu = 0.43 log K(IAM) + 0.23 log K(HSA)  - 0.72                           (12)  
 (n=70, R
2
= 0.84, s=0.32) 
The unbound volume of distribution is an important pharmacokinetic parameter since it is in principle 
the reciprocal value of the maximum drug efficiency (DEmax) defined by Braggio et al. [68]. 
Cell accumulation and retention may be very important for drug action in particular for drugs which are 
intended to penetrate to intracellular targets or intracellular pathogens, as well as to maintain a prolonged 
presence in the inflammatory cells [69]. Encouraging results have been reported by Gordon et al. [70] 
when plotting the log cell concentration, determined by the High-Throughput Screening Assay RapidFire, 
versus log k(IAM) A positive trend was observed with a correlation coefficient R=0.69, while the 
corresponding correlation with clogP showed a correlation coefficient R=0.42. 
The use of IAM chromatography for the prediction of ecotoxicity 
The environment is continuously exposed to a great variety of chemical substances coming from 
industrial, agricultural, municipal and natural physicochemical and biological processes. New compounds 
are synthesized and tested as drugs, ingredients of cosmetics, food additives, pesticides, plasticizers or for 
general use in technical and industrial purposes, while others can be produced as a result of natural 
biological processes [71]. Responsible product design should take into consideration the possible risks in 
human health and to ecosystems. The evaluation of ecotoxicity indices is involved in the REACH regulation 
“no data no market” [72]. Among other eco-toxicological endpoints, median toxicity, i.e. lethal 
concentration LC50 in aquatic organisms and lethal dose, LD50, for terrestrial organisms as well as 
bioaccumulation are of major importance. Experimental measurements on biological organisms for the 
thousands of compounds for various uses are simply not possible.  
In silico systems can be employed for ecotoxicological investigations, in which the logarithm of the 
octanol-water partition coefficient, symbolized in such studies as log Kow, is a principal parameter [73].  
Several authors have proposed linear solvation energy relationships (LSER) for ecological risk assessment 
[71,74-81]. However, failure in the selection of the appropriate model can result in a 1000-fold error in the 
estimated indices [82]. A popular predictive tool for environmental investigations is the estimation 
program interface (EPI Suite) software, freely available from the Environmental Protection Agency (EPA) 
[83]. Module BCFBAF, based on the work of Meylan et al. [84], calculates fish the bioconcentration factor 
and ECOSAR module, based on the work of Russon et al. [82], and estimates the aquatic toxicity of 
compounds.  
Chromatographic techniques offer an experimental alternative for the rapid evaluation of 
ecotoxicological endpoints. Bio-partitioning liquid chromatography (BLC), as named by the Escuder-Gilabert 
group [85] was the first biomimetic liquid chromatographic approach implemented for ecotoxicological 
purposes. BLC uses micellar mobile phases formed mainly by the addition of the non-ionic surfactant 
polyoxyethylene(23)lauryl ether (Brij35). It has been employed for the predictions of bioconcentration 
factors [86,87], skin permeability [87] and toxicity (pLC50 in fathead minnow) [88] of xenobiotics.  
In recent years, IAM technology has unfolded new perspectives in the field of ecotoxicology. As IAM 
retention factors reflect permeability of xenobiotics through cell membranes governed by passive diffusion 
as well as membrane accumulation, it is plausible that it can be used to provide ecotoxicological indices to 
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express median toxicity and bioconcentration or to construct a lipophilicity scale. Stepnowski and 
Storoniak [89] compared IAM and reversed phase retention as well as octanol-water partitioning as 
lipophilicity indices of hydrophilic imidazolium ionic liquids. The extrapolated log kw(IAM) values were higher 
than the corresponding logkw on reversed- phase stationary phases and log P, due to the development of 
electrostatic interactions of the positively charged nitrogen of the solutes with the phosphate anions of the 
IAM surface [89]. An analogous investigation was performed by Janicka [90], who compared IAM with 
reversed- phase, cholesterol phase and micellar chromatography. The authors used retention under the 
different chromatographic conditions as lipophilicity indices for 15 phenoxyacetic and carbamic acid 
derivatives with potential use as herbicides. Comparison with in silico calculated biological endpoints 
showed that all of the chromatographic indices were promising measures for the partitioning of chemicals 
in water- plant cuticle, water- human serum albumin and water- skin systems [90]. Cimpean et al. 
correlated IAM retention factors in the presence of 10% methanol with the non- specific toxicity (-log LC50) 
of the fathead minnow fish (Pimephales promelas) [91]. Hidalgo- Rodriguez et al. [92,93] and Fernandez- 
Pumarega et al. [94] measured retention on several chromatographic and electrophoretic systems in order 
to find the best conditions to emulate non-specific aquatic toxicity and soil sorption. As aquatic toxicity 









) [94] were used, while soil sorption was also considered, expressed by the 
logarithm of the organic carbon normalized sorption coefficient, log Koc [93]. Chromatographic and 
ecotoxicological data were submitted to LSER analysis.  Comparison of the solvation parameter models 
(SPM) was based on the distance parameter d (the difference between the coefficients of the respective 
SPMs), on the precision of biological-chromatographic correlations, on principal component analysis (PCA) 
of the coefficients of the compared systems and on dendrogram plots. Finally, the chromatographic indices 
selected according to the above tools were directly correlated with the ecotoxicological data.  For aquatic 
toxicity, IAM chromatography along with micellar electrokinetic chromatography based on sodium 
taurocholate showed the best predictive performance [92,94]. Furthermore, IAM and electrokinetic 
chromatography based either on sodium dodecyl sulfate or sodium taurocholate provided the most precise 
correlation models for soil sorption. Especially, the IAM model showed the lowest experimental error as 
reflected in the standard deviation between the observed and calculated data [92]. 
The potential of IAM chromatography to predict bioconcentration of pharmaceutical compounds in 
aquatic organisms was recently investigated by our group [21]. Since very limited experimental 
bioconcentration factors (BCF) of pharmaceutical compounds are available, BCF values predicted by EPI 
Suite Software were used to compile a data set of 125 structurally diverse drugs. EPI Suite Software 
employs log kow (log P calculated according to Meylan et al. [84]) as a major descriptor for BCF calculations, 
while for ionic and highly hydrophilic compounds an arbitrary value of log BCF = 0.50 is assigned by the 
software. Therefore, such drugs were excluded from the analysis and were posteriori predicted by the IAM 
model. Highly significant linear log BCF/ log kw(IAM) values were established. The constructed model was 
improved by the inclusion of the parameter BioWin5, which expresses the decrease in the bioaccumulation 
tendency as a result of the degradation potential of the compounds. BioWin5 is predicted by the EPI Suite 
Software and is included also in the EPI-BCF model. The log BCF/ log kw(IAM) relationship is shown in Eq.(13) 
[21]: 
Log BCF = 0.85 · log 7.4w(IAM)k  - 0.47 · BioWin5 + 0.08      (13) 
(n= 77, R2= 0.761, s= 0.437) 
ADMET & DMPK 6(3) (2018) 225-241 IAM chromatography in medicinal chemistry and environment 
doi: 10.5599/admet.553 235 
Validation of the constructed models was based on a test set of drugs with experimentally determined 
BCF values reported in the literature. Predictions of the test set were compared with those provided by the 
EPI software and in most cases, they were in favour of the IAM model. This can be explained on the basis 
that log kw(IAM) values involved electrostatic interactions due to ionization of the species at a pH close to 
those of a marine/ freshwater environment, while log kow is refers only to a neutral species expressing only 
a lipid- driven bioconcentration [95].  
In recent work by Russo et al. [96], the IAM phospholipophilicity of seven bisphenol A analogues was 
compared with toxicity investigated on four different cell cultures. Results showed that the ranking of 
toxicity according to the cell cultures was partly consistent with the IAM retention, indicating that toxicity 
increases with increasing membrane affinity [96]. 
Unpublished results from our research group have revealed the ability of IAM chromatography to model 
median toxicity of a series of structurally diverse pesticides in aquatic organisms, involving fish species (e.g. 
Fathead Minnow and Rainbow Trout), Eastern Oyster and Water Flea as well as in honey bee. In 
comparison with octanol-water partitioning, models based on log kw(IAM) demonstrate equal or superior 
statistics and, in some cases, they do not require the use of any additional physicochemical or topological 
parameters [97]. 
Conclusions 
The nature of IAM retention is between passive diffusion and binding underlines its potential for 
numerous applications in the field of pharmaceutical and environmental sciences. An increasing number of 
publications suggest that IAM indices can be an equal or even a more effective tool than traditional 
octanol-water partitioning to express the passage of xenobiotics through biological membranes and 
barriers as well as drug-membrane interactions. The great advantages are speed, reproducibility and low 
analyte consumption, as well as the flexibility to provide more than one index (different isocratic log k(IAM), 
extrapolated log kw(IAM), CHI(IAM) or Δlog kw(IAM)) which can be alternatively used in correlation with biological 
endpoints. In addition, pharmacokinetic parameters like the volume of distribution or the fraction of 
unbound in tissue can be easily estimated on the basis of IAM chromatographic indices, while they may 
also serve for drug classification according to certain properties, such as CNS penetration or 
phospholipidosis potential. Less investigated has been the performance of IAM chromatography in 
predicting the toxicity of candidate drugs and ecotoxicity of xenobiotics as well as the combined use of IAM 
with other biomimetic chromatographic indices.  Such studies need to be extended to further toxicity 
endpoints (e.g. cardiotoxicity) and ecotoxicity indices on terrestrial organisms (e.g. honey bee).  
The promising results obtained mainly in modelling pharmacokinetic and drug efficacy related 
properties and, more recently, also in ecotoxicology suggest that a broader application of IAM 
chromatography in early drug discovery processes and in environmental science may save time and money 
in initial drug candidate selection and contribute to a reduced risk hazard of chemicals. The high intra-
laboratory reproducibility of logkw(IAM) and CHI(IAM) values under analogous conditions permits their 
incorporation in to databases which could  then serve as a tool for classification purposes, as well as to 
expand the drug- like concept, by incorporating limit values or ranges for IAM chromatographic indices. 
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